Crossmark

MRI-based, three-dimensionally assessed tumor burden and growth velocity to predict visual acuity deterioration in optic pathway glioma — results of a retrospective longitudinal analysis

Crossref DOI link: https://doi.org/10.1007/s00381-025-06890-6

Published Online: 2025-07-11

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gorodezki, David

Tonagel, Felix

Zipfel, Julian

Mezger, Markus

Haas-Lude, Karin

Holzer, Ursula

Nägele, Thomas

Schuhmann, Martin Ulrich

Ebinger, Martin
Funding

Funding for this research was provided by:

Universitätsklinikum Tübingen
License Information

Text and Data Mining valid from 2025-07-11

Version of Record valid from 2025-07-11
More Information

Article History

Received: 8 April 2025

Accepted: 29 June 2025

First Online: 11 July 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical Faculty and University Hospital of Tübingen (NO 762/2021B02). Individual consent was waived.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below